Valanafusp alfa
Based on 1 Customer Validation
Valanafusp alfa (AGT-181) is a chimeric monoclonal antibody that fuses human α-L-iduronidase (IDUA) and targets the human insulin receptor (HIR). Valanafusp alfa has brain penetrating properties, making it useful for research on mucopolysaccharidosis type I (MPS I).
For research use only. We do not sell to patients.
- Purity : 98.42%
- CAS No.: 1815583-32-4
- Molecular Weight:284.23 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-108743
Insulin degludecInsulin Analogue -
HY-P99665
Insulin efsitora alfaInsulin Receptor Agonist -
HY-145935
NT219IRS1/2/STAT3 Inhibitor -
HY-15481
KU14RKATP Channel Inhibitor -
HY-112720
AGL-2263Insulin Receptor Inhibitor -
HY-N0628
KaempferitrinInsulin Receptor Activator -
HY-P3255
DA-JC4GLP-1/GIP Receptor Agonist -
HY-P0035
Insulin (human)Recombinant Human Insulin -
HY-P0035A
Insulin solution (human)Polypeptide Hormone -
HY-10191
LinsitinibIGF-1R/Insulin Receptor Inhibitor -
HY-119152
CMX-2043α-Lipoic Acid Analogue -
HY-P3584
(Pro3) GIP, humanhGIPR Agonist
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
In Vitro
Valanafusp alfa (HIRMAb-IDUA) binds to the HIR extracellular domain (ECD) with an EC50 of 0.93±0.07 nM[2].
Valanafusp alfa (HIRMAb-IDUA) (0.3 μg/mL; 48 h) reduces glycosoaminoglycan accumulation in Hurler fibroblasts by 70% as compared to healthy fibroblasts[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Valanafusp alfa (AGT-181) (0.2-20 mg/kg; IV) is stable, and shows rapid clearance and the high systemic volume of distribution in Rhesus monkeys[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1815583-32-4
-
Appearance Liquid
-
Molecular Weight 284.23 kDa
-
Color Colorless to light yellow
-
SMILES
[Valanafusp alfa]
-
Synonyms
AGT-181; HIRMAb-IDUA
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Boado RJ, et al. AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys. J Biotechnol. 2009 Oct 26;144(2):135-41. [Content Brief]
[2]. Boado RJ, et al. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier. Biotechnol Bioeng. 2008 Feb 1;99(2):475-84. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Valanafusp alfa Related Classifications
HY-P99530 Related Classifications
Powered by Bioz